Deprescribing is finally getting more attention in studies and from Medicare.
A study investigated the impact of deprescribing antihypertensive medication on cognitive function in older nursing home residents. The research, which included 12,644 residents aged 65 or older, found that reducing or discontinuing antihypertensive medications was linked to less cognitive decline, particularly among those with dementia.
Key Findings:
- Deprescribing was associated with a 12% reduced risk of cognitive decline (measured by the Cognitive Function Scale) compared to those who continued their antihypertensive medications.
- Among residents with dementia, the odds of cognitive decline were reduced by 16% with deprescribing.
- These findings highlight the potential benefits of tailoring antihypertensive treatments to optimize cognitive health in older adults, especially those with dementia.
Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents - PubMed
This cohort study indicates that deprescribing is associated with less cognitive decline in nursing home residents, particularly those with dementia. More data are needed to understand the benefits and harms of antihypertensive deprescribing to inform patient-centered medication management in nursin…
Bocheng Jing
